Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 7276463, 9 pages
http://dx.doi.org/10.1155/2016/7276463
Research Article

Dietary Biotin Supplementation Modifies Hepatic Morphology without Changes in Liver Toxicity Markers

1Unidad de Genética de la Nutrición, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Instituto Nacional de Pediatría, Avenida del Imán 1, 4th Floor, Colonia Insurgentes Cuicuilco, 04530 Mexico City, Mexico
2Centro de Investigación Científica y de Educación Superior de Ensenada, Carretera Ensenada-Tijuana No. 3918, Zona Playitas, 22860, Ensenada, BC, Mexico
3Laboratorio de Neurosciencias, Instituto Nacional de Pediatría, Avenida del Imán 1, 3rd Floor, Colonia Insurgentes Cuicuilco, 04530 Mexico City, Mexico

Received 7 October 2016; Revised 28 November 2016; Accepted 30 November 2016

Academic Editor: Marija Mostarica-Stojković

Copyright © 2016 Leticia Riverón-Negrete et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. S. Harper, “C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (eds.), B. Childs, K.W. Kinzler, B. Vogelstein (associate eds.): molecular and metabolic bases of inherited disease, 8th edition,” Human Genetics, vol. 110, no. 2, pp. 205–206, 2002. View at Publisher · View at Google Scholar
  2. A. A. Yates, S. A. Schlicker, and C. W. Suitor, “Dietary Reference Intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline,” Journal of the American Dietetic Association, vol. 98, no. 6, pp. 699–706, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Fernandez-Mejia and M.-L. Lazo-de-la-Vega-Monroy, “Biological effects of pharmacological concentrations of biotin,” Journal of Evidence-Based Complementary and Alternative Medicine, vol. 16, no. 1, pp. 40–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Revilla-Monsalve, I. Zendejas-Ruiz, S. Islas-Andrade et al., “Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia,” Biomedicine and Pharmacotherapy, vol. 60, no. 4, pp. 182–185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. O. K. Dokusova and I. V. Krivoruchenko, “The effect of biotin on the level of cholesterol in the blood of patients with atherosclerosis and essential hyperlipidemia,” Kardiologiia, vol. 12, no. 12, p. 113, 1972. View at Google Scholar
  6. M. W. Marshall, P. G. Kliman, V. A. Washington, J. F. Mackin, and B. T. Weinland, “Effects of biotin on lipids and other constituents of plasma of healthy men and women,” Artery, vol. 7, no. 4, pp. 330–351, 1980. View at Google Scholar · View at Scopus
  7. M. Hemmati, H. Babaei, and M. Abdolsalehei, “Survey of the effect of biotin on glycemic control and plasma lipid concentrations in type 1 diabetic patients in Kermanshah in Iran (2008-2009),” Oman Medical Journal, vol. 28, no. 3, pp. 195–198, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Albarracin, B. Fuqua, J. Geohas, M. Finch, and J. Komorowski, “Improvement in glycemic control, lipids and insulin sensitivity with the combination of chromium picolinate and biotin in type 2 diabetes mellitus,” Diabetes Care, vol. 54, article A428, 2005. View at Google Scholar
  9. J. C. Coggeshall, J. P. Heggers, M. C. Robson, and H. Baker, “Biotin status and plasma glucose in diabetics,” Annals of the New York Academy of Sciences, vol. 447, pp. 389–392, 1985. View at Publisher · View at Google Scholar
  10. M. Maebashi, Y. Makino, Y. Furukawa, K. Ohinata, S. Kimura, and T. Sato, “Therapeutic evaluation of the effect of biotin on hyperglycemia in patients with non-insulin dependent diabetes mellitus,” Journal of Clinical Biochemistry and Nutrition, vol. 14, no. 3, pp. 211–218, 1993. View at Publisher · View at Google Scholar
  11. D. Koutsikos, C. Fourtounas, A. Kapetanaki et al., “Oral glucose tolerance test after high-dose i.v. biotin administration in normoglucemic hemodialysis patients,” Renal Failure, vol. 18, no. 1, pp. 131–137, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Sahin, M. Tuzcu, C. Orhan et al., “Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin,” British Journal of Nutrition, vol. 110, no. 2, pp. 197–205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Koutsikos, B. Agroyannis, and H. Tzanatos-Exarchou, “Biotin for diabetic peripheral neuropathy,” Biomedicine & Pharmacotherapy, vol. 44, no. 10, pp. 511–514, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Sugita, H. Shirakawa, R. Sugimoto, Y. Furukawa, and M. Komai, “Effect of biotin treatment on hepatic gene expression in streptozotocin-induced diabetic rats,” Bioscience, Biotechnology and Biochemistry, vol. 72, no. 5, pp. 1290–1298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. L. Lazo de la Vega-Monroy, E. Larrieta, M. S. German, A. Baez-Saldana, and C. Fernandez-Mejia, “Effects of biotin supplementation in the diet on insulin secretion, islet gene expression, glucose homeostasis and beta-cell proportion,” Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 169–177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Aguilera-Méndez and C. Fernández-Mejía, “The hypotriglyceridemic effect of biotin supplementation involves increased levels of cGMP and AMPK activation,” BioFactors, vol. 38, no. 5, pp. 387–394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Larrieta, F. Velasco, P. Vital et al., “Pharmacological concentrations of biotin reduce serum triglycerides and the expression of lipogenic genes,” European Journal of Pharmacology, vol. 644, no. 1-3, pp. 263–268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Boone-Villa, A. Aguilera-Méndez, A. Miranda-Cervantes, and C. Fernandez-Mejia, “Effects of biotin supplementation in the diet on adipose tissue cGMP concentrations, AMPK activation, lipolysis, and serum-free fatty acid levels,” Journal of Medicinal Food, vol. 18, no. 10, pp. 1150–1156, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Báez-Saldaña, I. Camacho-Arroyo, J. J. Espinosa-Aguirre et al., “Biotin deficiency and biotin excess: effects on the female reproductive system,” Steroids, vol. 74, no. 10-11, pp. 863–869, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. K. Paul, P. N. Duttagupta, and H. C. Agarwal, “Effects of an acute dose of biotin on the reproductive organs of the female rat,” Current Science, vol. 42, no. 6, pp. 206–208, 1973. View at Google Scholar · View at Scopus
  21. H. Sawamura, C. Ikeda, R. Shimada, Y. Yoshii, and T. Watanabe, “Dietary intake of high-dose biotin inhibits spermatogenesis in young rats,” Congenital Anomalies, vol. 55, no. 1, pp. 31–36, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. B. A. Aldahmash, D. M. El-Nagar, and K. E. Ibrahim, “Attenuation of hepatotoxicity and oxidative stress in diabetes STZ-induced type 1 by biotin in Swiss albino mice,” Saudi Journal of Biological Sciences, vol. 23, no. 2, pp. 311–317, 2016. View at Publisher · View at Google Scholar
  23. B. A. Aldahmash, D. M. El-Nagar, K. E. Ibrahim, and M. S. Metwaly, “Biotin amelioration of nephrotoxicity in streptozotocin-induced diabetic mice,” Saudi Journal of Biological Sciences, vol. 22, no. 5, pp. 564–569, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. G. M. Singer and J. Geohas, “The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial,” Diabetes Technology and Therapeutics, vol. 8, no. 6, pp. 636–643, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Z. Fiume, “Final report on the safety assessment of Biotin,” International Journal of Toxicology, vol. 20, supplement 4, pp. 1–12, 2001. View at Google Scholar · View at Scopus
  26. A. Báez-Saldaña and E. Ortega, “Biotin deficiency blocks thymocyte maturation, accelerates thymus involution, and decreases nose-rump length in mice,” Journal of Nutrition, vol. 134, no. 8, pp. 1970–1977, 2004. View at Google Scholar · View at Scopus
  27. H. H. Draper and M. Hadley, “Malondialdehyde determination as index of lipid peroxidation,” Methods in Enzymology, vol. 186, pp. 421–431, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Góth, “A simple method for determination of serum catalase activity and revision of reference range,” Clinica Chimica Acta, vol. 196, no. 2-3, pp. 143–151, 1991. View at Publisher · View at Google Scholar · View at Scopus
  29. S. A. Mansour and A. H. Mossa, “Adverse effects of lactational exposure to chlorpyrifos in suckling rats,” Human and Experimental Toxicology, vol. 29, no. 2, pp. 77–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. C. R. Laboratories, BALB/c Nude Mouse Biochemistry, 2012, http://www.criver.com/files/pdfs/rms/balbc-nude/rm_rm_r_balb-c_nude_mouse_clinical_pathology_data.aspx.
  31. R. Rodriguez-Melendez and J. Zempleni, “Nitric oxide signaling depends on biotin in Jurkat human lymphoma cells,” Journal of Nutrition, vol. 139, no. 3, pp. 429–433, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Gentric and C. Desdouets, “Polyploidization in liver tissue,” The American Journal of Pathology, vol. 184, no. 2, pp. 322–331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Gentric and C. Desdouets, “Liver polyploidy: Dr Jekyll or Mr Hide?” Oncotarget, vol. 6, no. 11, pp. 8430–8431, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. A. W. Duncan, “Aneuploidy, polyploidy and ploidy reversal in the liver,” Seminars in Cell and Developmental Biology, vol. 24, no. 4, pp. 347–356, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Sawamura, T. Fukuwatari, and K. Shibata, “Effects of excess biotin administration on the growth and urinary excretion of water-soluble vitamins in young rats,” Bioscience, Biotechnology and Biochemistry, vol. 71, no. 12, pp. 2977–2984, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Ferreira and W. P. Weiss, “Effect of biotin on activity and gene expression of biotin-dependent carboxylases in the liver of dairy cows,” Journal of Dairy Science, vol. 90, no. 3, pp. 1460–1466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Dakshinamurti and W. Li, “Transcriptional regulation of liver phosphoenolpyruvate carboxykinase by biotin in diabetic rats,” Molecular and Cellular Biochemistry, vol. 132, no. 2, pp. 127–132, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Reddi, B. DeAngelis, O. Frank, N. Lasker, and H. Baker, “Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK mice,” Life Sciences, vol. 42, no. 13, pp. 1323–1330, 1988. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Bhandari, R. Choo-Wing, S. P. Chapoval et al., “Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 29, pp. 11021–11026, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Watanabe-Kamiyama, S. Kamiyama, K. Horiuchi et al., “Antihypertensive effect of biotin in stroke-prone spontaneously hypertensive rats,” British Journal of Nutrition, vol. 99, no. 4, pp. 756–763, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Esni, I.-B. Täljedal, A.-K. Perl, H. Cremer, G. Christofori, and H. Semb, “Neural cell adhesion molecule (N-CAM) is required for cell: type segregation and normal ultrastructure in pancreatic islets,” Journal of Cell Biology, vol. 144, no. 2, pp. 325–337, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Hayes, A. Gordon, I. Sadowski, and C. Hayes, “RK bacterial test for independently measuring chemical toxicity and mutagenicity: Short-term forward selection assay,” Mutation Research/Environmental Mutagenesis and Related Subjects, vol. 130, no. 2, pp. 97–106, 1984. View at Publisher · View at Google Scholar · View at Scopus
  43. SRI-International, “Microbial mutagenesis testing of substances compound report: F76-041, D-Biotin,” NTIS Report PB89-169072, 1979. View at Google Scholar
  44. M. D. Ronquillo-Sánchez, R. Camacho-Carranza, C. Fernandez-Mejia, S. Hernández-Ojeda, M. Elinos-Baez, and J. J. Espinosa-Aguirre, “Modulation of the rat hepatic cytochrome P4501A subfamily using biotin supplementation,” BioMed Research International, vol. 2013, Article ID 627907, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. T.-H. Ma, M. M. Harris, V. A. Anderson et al., “Tradescantia-micronucleus (Trad-MCN) tests on 140 health-related agents,” Mutation Research/Genetic Toxicology, vol. 138, no. 2-3, pp. 157–167, 1984. View at Publisher · View at Google Scholar · View at Scopus
  46. E. R. Baumgartner and T. Suormala, “Multiple carboxylase deficiency: inherited and acquired disorders of biotin metabolism,” International Journal for Vitamin and Nutrition Research, vol. 67, no. 5, pp. 377–384, 1997. View at Google Scholar · View at Scopus